JP2025105692A5 - - Google Patents

Info

Publication number
JP2025105692A5
JP2025105692A5 JP2025068825A JP2025068825A JP2025105692A5 JP 2025105692 A5 JP2025105692 A5 JP 2025105692A5 JP 2025068825 A JP2025068825 A JP 2025068825A JP 2025068825 A JP2025068825 A JP 2025068825A JP 2025105692 A5 JP2025105692 A5 JP 2025105692A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025068825A
Other languages
Japanese (ja)
Other versions
JP2025105692A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/053214 external-priority patent/WO2020161341A1/en
Application filed filed Critical
Publication of JP2025105692A publication Critical patent/JP2025105692A/ja
Publication of JP2025105692A5 publication Critical patent/JP2025105692A5/ja
Pending legal-status Critical Current

Links

JP2025068825A 2019-02-08 2025-04-18 変形性関節症が急速に進行するリスクがある患者の治療 Pending JP2025105692A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP19156281 2019-02-08
EP19156281.8 2019-02-08
PCT/EP2020/053214 WO2020161341A1 (en) 2019-02-08 2020-02-07 Treatment of patients at risk of rapid progression of osteoarthritis
JP2021546319A JP7671249B2 (ja) 2019-02-08 2020-02-07 変形性関節症が急速に進行するリスクがある患者の治療

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021546319A Division JP7671249B2 (ja) 2019-02-08 2020-02-07 変形性関節症が急速に進行するリスクがある患者の治療

Publications (2)

Publication Number Publication Date
JP2025105692A JP2025105692A (ja) 2025-07-10
JP2025105692A5 true JP2025105692A5 (enExample) 2025-09-30

Family

ID=65365897

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021546319A Active JP7671249B2 (ja) 2019-02-08 2020-02-07 変形性関節症が急速に進行するリスクがある患者の治療
JP2025068825A Pending JP2025105692A (ja) 2019-02-08 2025-04-18 変形性関節症が急速に進行するリスクがある患者の治療

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021546319A Active JP7671249B2 (ja) 2019-02-08 2020-02-07 変形性関節症が急速に進行するリスクがある患者の治療

Country Status (7)

Country Link
US (1) US20220184180A1 (enExample)
EP (1) EP3920959A1 (enExample)
JP (2) JP7671249B2 (enExample)
AU (1) AU2020218844A1 (enExample)
CA (1) CA3127729A1 (enExample)
IL (1) IL285420A (enExample)
WO (1) WO2020161341A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003279835B2 (en) 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
US8207115B2 (en) 2006-08-25 2012-06-26 Ares Trading S.A. Treatment of cartilage disorders with FGF-18
WO2012038953A2 (en) * 2010-09-21 2012-03-29 Hepacore Ltd. Fgf-18 truncated variants having increased receptor specificity and uses thereof
AU2013301606B2 (en) 2012-08-06 2018-08-02 Merck Patent Gmbh Genetic markers for predicting responsiveness to FGF-18 compound
US9724388B2 (en) * 2014-02-20 2017-08-08 Merck Patent Gmbh FGF-18 compound dosing regimen

Similar Documents

Publication Publication Date Title
JP2025105692A5 (enExample)
RU2024133813A3 (enExample)
CN309385200S (enExample)
CN309604850S (enExample)
CN309683239S (enExample)
CN309657466S (enExample)
CN309657267S (enExample)
CN309648800S (enExample)
CN309646828S (enExample)
CN309611635S (enExample)
CN309439570S (enExample)
CN309253737S (enExample)
CN309249760S (enExample)
CN308487787S (enExample)
CN308419181S (enExample)
CN308409028S (enExample)
CN308409003S (enExample)
CN308408954S (enExample)
CN308408848S (enExample)
CN308408815S (enExample)
CN308408592S (enExample)
CN308404278S (enExample)
CN308408484S (enExample)
CN308408427S (enExample)
CN308408362S (enExample)